165947-51-3

Basic information

• Product Name: 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid
• Synonyms: 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid;Thieno[2,3-c]pyridine-2,6(5H)-dicarboxylic acid, 4,7-dihydro-, 6-(1,1-diMethylethyl) ester;6-BOC-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID
• CAS NO: 165947-51-3
• Molecular Formula: C13H17NO4S
• Molecular Weight: 283.34338
• Mol File: 165947-51-3.mol

Chemical Properties

• Boiling Point: 453.2°C at 760 mmHg
• Flash Point: 227.9°C
• Appearance: /
• Density: 1.308
• Vapor Pressure: 5.31E-09mmHg at 25°C
• Refractive Index: 1.58
• CAS DataBase Reference: 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid(165947-51-3)
• EPA Substance Registry System: 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid(165947-51-3)

Safety Data

• Hazardous Substances Data: 165947-51-3(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid is used as a precursor in the synthesis of new pharmaceutical compounds for the treatment of certain diseases. Its unique structure and functional groups provide a versatile platform for the development of innovative drugs with potential therapeutic benefits.
Used in Drug Development:
In the pharmaceutical industry, 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid is utilized as a key intermediate in the design and synthesis of novel drug candidates. Its presence of a protecting group allows for selective reactions and modifications, facilitating the creation of diverse drug molecules with improved efficacy and selectivity.
Used in Organic Chemistry Research:
6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid serves as an interesting target for research in organic chemistry. Its complex structure and functional groups offer opportunities for exploring new synthetic pathways, reaction mechanisms, and the development of innovative synthetic strategies.
Used in Chemical Synthesis:
In the field of chemical synthesis, 6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid is employed as a building block for the creation of more complex organic molecules. Its unique structural features and the presence of a protecting group make it a valuable component in the synthesis of advanced organic compounds with potential applications in various industries.

InChI:InChI=1/C13H17NO4S/c1-13(2,3)18-12(17)14-5-4-8-6-9(11(15)16)19-10(8)7-14/h6H,4-5,7H2,1-3H3,(H,15,16)

Upstream product

• 478148-99-1 ethyl thieno[2,3-c]pyridine-2-carboxylate 
• 40273-47-0 3-fluoropyridine-4-carbaldehyde 
• 62019-71-0 4,5,6,7-tetrahydro-thieno[2,3-c]pyridine 
• 124-38-9 carbon dioxide 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1415762-96-7 N-{[2-(4-amidino-2-fluorophenoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-6-yl]carbonyl}-L-aspartic acid trifluoroacetate 

Relevant articles and documents

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

Tetrahydrothienopyridine derivatives as novel GPIIB/IIIA antagonists

The tetrahydrothienopyridine derivatives were derived from aminomethylcyclohexylcarboxylic acid as a lead moiety. Evaluation of the antiplatelet activity and receptor binding assay revealed that compound 1 (Me3277) was a novel and potent non-peptide and n